NCT00004414View on ClinicalTrials.gov

Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis

NACompletedINTERVENTIONAL

Enrollment

252

Participants

Timeline

Start Date

September 30, 1997

Study Completion Date

June 30, 2002

Conditions

Cholestasis

Interventions

DRUG

sincalide

Trial Locations (6)

14642

University of Rochester Medical Center, Rochester

21231

Johns Hopkins Oncology Center, Baltimore

75246

Baylor University Medical Center, Dallas

48109-0718

University of Michigan Medical School, Ann Arbor

45229-3039

Children's Hospital Medical Center - Cincinnati, Cincinnati

02903

Rhode Island Hospital, Providence

All Listed Sponsors

lead

University of Michigan

OTHER

NCT00004414 - Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis | Biotech Hunter | Biotech Hunter